Galen buys clinical trial businesses for $13 million

Galen (LSE:GAL) acquired Applied Clinical Concepts (Durham, N.C.) and the Pharmacy Division of Duke Clinical Research Institute (Durham, N.C.) for $13 million in cash. GAL will use the two pharmacies,...